it is not clear why the authors did not use ondansetron as a prophylactic agent because this drug has uncommon side effects (e.g., dizziness, headache) and has been recommended by recent PONV guidelines developed by panel members of the Society of Ambulatory Anesthesia [5] . The guidelines provide information about strategies that health care providers can implement to prevent and treat PONV in adults and children undergoing surgery. Lastly, it is unclear why the author did not use a patient-centered outcome to evaluate the clinical impact of their findings.
We would welcome comments from the authors regarding the aforementioned issues to further strengthen the findings of this important study.
